Avantor, Inc. (NYSE:AVTR) Shares Sold by Swiss National Bank

Swiss National Bank lessened its stake in shares of Avantor, Inc. (NYSE:AVTR) by 4.7% during the fourth quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 1,920,500 shares of the company’s stock after selling 95,600 shares during the quarter. Swiss National Bank owned about 0.28% of Avantor worth $40,465,000 at the end of the most recent reporting period.

Other large investors have also recently bought and sold shares of the company. MassMutual Private Wealth & Trust FSB boosted its holdings in shares of Avantor by 99.5% during the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,253 shares of the company’s stock worth $26,000 after purchasing an additional 625 shares during the last quarter. Smartleaf Asset Management LLC boosted its holdings in shares of Avantor by 106.3% during the fourth quarter. Smartleaf Asset Management LLC now owns 1,611 shares of the company’s stock worth $34,000 after purchasing an additional 830 shares during the last quarter. Global Retirement Partners LLC boosted its holdings in shares of Avantor by 76.7% during the fourth quarter. Global Retirement Partners LLC now owns 2,459 shares of the company’s stock worth $52,000 after purchasing an additional 1,067 shares during the last quarter. UMB Bank n.a. boosted its holdings in shares of Avantor by 56.3% during the fourth quarter. UMB Bank n.a. now owns 2,981 shares of the company’s stock worth $63,000 after purchasing an additional 1,074 shares during the last quarter. Finally, AlphaQuest LLC acquired a new stake in shares of Avantor during the fourth quarter worth $65,000. Institutional investors and hedge funds own 95.08% of the company’s stock.

Avantor Trading Up 3.3 %

Shares of AVTR opened at $16.34 on Monday. The stock’s 50-day moving average is $19.51 and its two-hundred day moving average is $22.01. The stock has a market cap of $11.12 billion, a PE ratio of 15.71, a P/E/G ratio of 1.55 and a beta of 1.30. Avantor, Inc. has a 12 month low of $15.37 and a 12 month high of $28.00. The company has a debt-to-equity ratio of 0.54, a current ratio of 1.07 and a quick ratio of 0.70.

Avantor (NYSE:AVTR) last issued its quarterly earnings data on Wednesday, February 12th. The company reported $0.27 EPS for the quarter, topping analysts’ consensus estimates of $0.26 by $0.01. Avantor had a return on equity of 12.17% and a net margin of 10.49%. During the same quarter in the previous year, the firm earned $0.22 EPS. Equities analysts forecast that Avantor, Inc. will post 1.06 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, EVP James Bramwell sold 3,758 shares of the business’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $65,877.74. Following the transaction, the executive vice president now owns 87,379 shares in the company, valued at approximately $1,531,753.87. The trade was a 4.12 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, CAO Steven W. Eck sold 4,907 shares of the business’s stock in a transaction dated Wednesday, February 26th. The stock was sold at an average price of $17.53, for a total value of $86,019.71. Following the completion of the transaction, the chief accounting officer now owns 40,604 shares in the company, valued at approximately $711,788.12. This trade represents a 10.78 % decrease in their position. The disclosure for this sale can be found here. 1.50% of the stock is currently owned by insiders.

Analyst Ratings Changes

AVTR has been the topic of several analyst reports. Raymond James restated an “outperform” rating and set a $24.00 price objective (down previously from $26.00) on shares of Avantor in a report on Monday, February 10th. Wells Fargo & Company cut their target price on Avantor from $28.00 to $25.00 and set an “overweight” rating on the stock in a research report on Monday, February 10th. UBS Group reaffirmed a “neutral” rating and issued a $25.00 target price (down from $29.00) on shares of Avantor in a research report on Friday, January 17th. Royal Bank of Canada cut their target price on Avantor from $33.00 to $31.00 and set an “outperform” rating on the stock in a research report on Monday, February 10th. Finally, Citigroup cut their target price on Avantor from $22.00 to $18.00 and set a “neutral” rating on the stock in a research report on Tuesday, March 4th. Three research analysts have rated the stock with a hold rating and nine have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and an average target price of $25.50.

Avantor Company Profile

Avantor, Inc engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle East, and Africa. The company offers materials and consumables, such as purity chemicals and reagents, lab products and supplies, formulated silicone materials, customized excipients, customized single-use assemblies, process chromatography resins and columns, analytical sample prep kits, education and microbiology products, clinical trial kits, peristaltic pumps, and fluid handling tips.